English
简体中文
Total: £ 56.28
Published Date: 2026-04-13 | Pages: 117 | Tables: 115 | New Technology
The global Ex Vivo Organ Perfusion market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.
Ex vivo organ perfusion is a technique used in transplantation and research to preserve and evaluate organs outside of the body before transplantation. During ex vivo perfusion, the organ is connected to a perfusion system that delivers oxygenated blood or a specialized preservation solution to maintain the organ's viability and function. This process allows for the assessment and optimization of organ function, as well as the potential for organ repair or treatment prior to transplantation. Ex vivo organ perfusion offers several advantages over traditional static cold storage, including the ability to assess organ viability, reduce ischemic injury, and potentially expand the donor pool by allowing for the use of marginal or extended criteria organs. Additionally, ex vivo perfusion enables researchers to study organ physiology, test new therapies, and improve transplantation outcomes.
The North American market for Ex Vivo Organ Perfusion is projected to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % over 2026–2032.
The Asia-Pacific market for Ex Vivo Organ Perfusion is projected to rise from US$ million in 2025 to US$ million by 2032, at a CAGR of % over 2026–2032.
The global market for Ex Vivo Organ Perfusion in Organ Transplant Specialist Hospitals is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 to 2032.
Major global companies of Ex Vivo Organ Perfusion include TransMedics, Lung Bioengineering, OrganOx, XVIVO, TNO, UHN, SCREEN, Bridge to Life, Organ Recovery Systems, Institut Georges Lopez, etc. In 2025, the world's top three vendors accounted for approximately % of revenue.
This report focuses on the global Ex Vivo Organ Perfusion status, future forecast, growth opportunity, key market, and key players. The study objectives are to present the Ex Vivo Organ Perfusion development in different regions.
It segments the global Ex Vivo Organ Perfusion market comprehensively. Regional market sizes by Type, by Application, , and by player are also provided. For deeper insight, the report profiles the competitive landscape, key competitors, and their respective market rankings, and discusses technological trends and new product developments.
This report will assist Ex Vivo Organ Perfusion manufacturers, new entrants, and companies across the industry value chain with information on revenues, sales volume, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.
Market Segmentation
By Company
TransMedics
Lung Bioengineering
OrganOx
XVIVO
TNO
UHN
SCREEN
Bridge to Life
Organ Recovery Systems
Institut Georges Lopez
Ebers
Penn Medicine
Johns Hopkins Medicine
Segment by Type
Heart Perfusion
Liver Perfusion
Kidney Perfusion
Lung Perfusion
Segment by Application
Organ Transplant Specialist Hospitals
Organ Banks
Pharmaceutical Research Organizations
By Region
North America
Europe
Asia-Pacific
Latin America
Middle East & Africa
Research Methodology
The research methodology employed has been subjected by numerous procedures in order to guarantee the quality and accuracy of the data contained within the reports. The analysts are employed full-time and received more than six months training to satisfy the standard of our company. Our methodology can be divided into five stages:
★Stage 1 SECONDARY RESEARCH
The research team first collaborates with magazines, trade associations and administrative departments in the research field. The information provided by our internal documentation service is helpful for our further research. Our team has a wealth of experience and knowledge, and can effectively extract accurate information from existing resources.
★Stage 2 PRIMARY RESEARCH:INTERVIEWS WITH TRADE SOURCES
After the first stage, the research team conducts a large number of face-to-face or telephone interviews with representative companies working in the research field. Analysts are trying to have an opportunity to talk to leading companies and small companies in the field. Upstream suppliers, manufacturers, distributors, importers, installers, wholesalers and consumers were included in the interview. The data collected during the interview were then carefully examined and compared with the secondary study.
★Stage 3 ANALYSIS OF THE GATHERED DATA
The analysis team examines and synthesizes the data collected in the first two stages. In order to validate the data, a second round of interviews can be conducted.
★Stage 4 QUANTITATIVE DATA
The quantitative data such as market estimates, production and capacity of manufacturer, market forecasts and investment feasibility is provided by our company. The data is based on the estimates obtained during stage 3.
★Stage 5 QUALITY CONTROL
Before publishing, each report undergoes a rigorous review and editing process, which is done by the experience management team to ensure the reliability of the published data. Every analyst on the research team receives support and continuous training as part of our internal quality process.
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Ex Vivo Organ Perfusion Market Size Growth Rate by Type (2026-2032)
1.2.2 Heart Perfusion
1.2.3 Liver Perfusion
1.2.4 Kidney Perfusion
1.2.5 Lung Perfusion
1.3 Market by Application
1.3.1 Global Ex Vivo Organ Perfusion Market Share by Application (2026-2032)
1.3.2 Organ Transplant Specialist Hospitals
1.3.3 Organ Banks
1.3.4 Pharmaceutical Research Organizations
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Ex Vivo Organ Perfusion Market Size
2.2 Ex Vivo Organ Perfusion Market Size by Region
2.2.1 Ex Vivo Organ Perfusion Growth Rate by Region (2026-2032)
2.2.2 Ex Vivo Organ Perfusion Market Share by Region (2026-2032)
2.3 Industry Trends
2.3.1 Market Top Trends
2.3.2 Market Use Cases
3 Key Players
3.1 Ex Vivo Organ Perfusion Revenue by Players (2026 & 2032)
3.2 Ex Vivo Organ Perfusion Key Players Headquarters and Area Served
3.3 Key Players Ex Vivo Organ Perfusion Product/Solution/Service
3.4 Date of Enter into Ex Vivo Organ Perfusion Market
3.5 Mergers & Acquisitions, Expansion Plans
4 Breakdown by Type and Application
4.1 Global Ex Vivo Organ Perfusion Market Size by Type (2026-2032)
4.2 Global Ex Vivo Organ Perfusion Market Size by Application (2026-2032)
5 North America
5.1 North America Ex Vivo Organ Perfusion Market Forecast (2026-2032)
5.2 Ex Vivo Organ Perfusion Key Players in North America
5.3 North America Ex Vivo Organ Perfusion Market Size by Type
5.4 North America Ex Vivo Organ Perfusion Market Size by Application
6 Europe
6.1 Europe Ex Vivo Organ Perfusion Market Forecast (2026-2032)
6.2 Ex Vivo Organ Perfusion Key Players in Europe
6.3 Europe Ex Vivo Organ Perfusion Market Size by Type
6.4 Europe Ex Vivo Organ Perfusion Market Size by Application
7 Asia-Pacific
7.1 Asia-Pacific Ex Vivo Organ Perfusion Market Forecast (2026-2032)
7.2 Ex Vivo Organ Perfusion Key Players in Asia-Pacific
7.3 Asia-Pacific Ex Vivo Organ Perfusion Market Size by Type
7.4 Asia-Pacific Ex Vivo Organ Perfusion Market Size by Application
8 Rest of World
8.1 Latin America
8.1.1 Latin America Ex Vivo Organ Perfusion Market Analysis
8.1.2 Key Players in Latin America
8.2 Middle East & Africa
8.2.1 Middle East & Africa Ex Vivo Organ Perfusion Market Analysis
8.2.2 Key Players in Middle East & Africa
9 International Players Profiles
9.1 TransMedics
9.1.1 TransMedics Company Details
9.1.2 TransMedics Description and Business Overview
9.1.3 TransMedics Ex Vivo Organ Perfusion Introduction
9.1.4 TransMedics Revenue in Ex Vivo Organ Perfusion Business (2026 & 2032)
9.1.5 TransMedics Recent Development
9.2 Lung Bioengineering
9.2.1 Lung Bioengineering Company Details
9.2.2 Lung Bioengineering Description and Business Overview
9.2.3 Lung Bioengineering Ex Vivo Organ Perfusion Introduction
9.2.4 Lung Bioengineering Revenue in Ex Vivo Organ Perfusion Business (2026 & 2032)
9.2.5 Lung Bioengineering Recent Development
9.3 OrganOx
9.3.1 OrganOx Company Details
9.3.2 OrganOx Description and Business Overview
9.3.3 OrganOx Ex Vivo Organ Perfusion Introduction
9.3.4 OrganOx Revenue in Ex Vivo Organ Perfusion Business (2026 & 2032)
9.3.5 OrganOx Recent Development
9.4 XVIVO
9.4.1 XVIVO Company Details
9.4.2 XVIVO Description and Business Overview
9.4.3 XVIVO Ex Vivo Organ Perfusion Introduction
9.4.4 XVIVO Revenue in Ex Vivo Organ Perfusion Business (2026 & 2032)
9.4.5 XVIVO Recent Development
9.5 TNO
9.5.1 TNO Company Details
9.5.2 TNO Description and Business Overview
9.5.3 TNO Ex Vivo Organ Perfusion Introduction
9.5.4 TNO Revenue in Ex Vivo Organ Perfusion Business (2026 & 2032)
9.5.5 TNO Recent Development
9.6 UHN
9.6.1 UHN Company Details
9.6.2 UHN Description and Business Overview
9.6.3 UHN Ex Vivo Organ Perfusion Introduction
9.6.4 UHN Revenue in Ex Vivo Organ Perfusion Business (2026 & 2032)
9.6.5 UHN Recent Development
9.7 SCREEN
9.7.1 SCREEN Company Details
9.7.2 SCREEN Description and Business Overview
9.7.3 SCREEN Ex Vivo Organ Perfusion Introduction
9.7.4 SCREEN Revenue in Ex Vivo Organ Perfusion Business (2026 & 2032)
9.7.5 SCREEN Recent Development
9.8 Bridge to Life
9.8.1 Bridge to Life Company Details
9.8.2 Bridge to Life Description and Business Overview
9.8.3 Bridge to Life Ex Vivo Organ Perfusion Introduction
9.8.4 Bridge to Life Revenue in Ex Vivo Organ Perfusion Business (2026 & 2032)
9.8.5 Bridge to Life Recent Development
9.9 Organ Recovery Systems
9.9.1 Organ Recovery Systems Company Details
9.9.2 Organ Recovery Systems Description and Business Overview
9.9.3 Organ Recovery Systems Ex Vivo Organ Perfusion Introduction
9.9.4 Organ Recovery Systems Revenue in Ex Vivo Organ Perfusion Business (2026 & 2032)
9.9.5 Organ Recovery Systems Recent Development
9.10 Institut Georges Lopez
9.10.1 Institut Georges Lopez Company Details
9.10.2 Institut Georges Lopez Description and Business Overview
9.10.3 Institut Georges Lopez Ex Vivo Organ Perfusion Introduction
9.10.4 Institut Georges Lopez Revenue in Ex Vivo Organ Perfusion Business (2026 & 2032)
9.10.5 Institut Georges Lopez Recent Development
9.11 Ebers
9.11.1 Ebers Company Details
9.11.2 Ebers Description and Business Overview
9.11.3 Ebers Ex Vivo Organ Perfusion Introduction
9.11.4 Ebers Revenue in Ex Vivo Organ Perfusion Business (2026 & 2032)
9.11.5 Ebers Recent Development
9.12 Penn Medicine
9.12.1 Penn Medicine Company Details
9.12.2 Penn Medicine Description and Business Overview
9.12.3 Penn Medicine Ex Vivo Organ Perfusion Introduction
9.12.4 Penn Medicine Revenue in Ex Vivo Organ Perfusion Business (2026 & 2032)
9.12.5 Penn Medicine Recent Development
9.13 Johns Hopkins Medicine
9.13.1 Johns Hopkins Medicine Company Details
9.13.2 Johns Hopkins Medicine Description and Business Overview
9.13.3 Johns Hopkins Medicine Ex Vivo Organ Perfusion Introduction
9.13.4 Johns Hopkins Medicine Revenue in Ex Vivo Organ Perfusion Business (2026 & 2032)
9.13.5 Johns Hopkins Medicine Recent Development
10 Ex Vivo Organ Perfusion Market Dynamics
10.1 Ex Vivo Organ Perfusion Industry Trends
10.2 Ex Vivo Organ Perfusion Market Drivers
10.3 Ex Vivo Organ Perfusion Market Challenges
10.4 Ex Vivo Organ Perfusion Market Restraints
11 Key Findings in This Report
12 Appendix
12.1 Research Methodology
12.1.1 Methodology/Research Approach
12.1.1.1 Research Programs/Design
12.1.1.2 Market Size Estimation
12.1.1.3 Market Breakdown and Data Triangulation
12.1.2 Data Source
12.1.2.1 Secondary Sources
12.1.2.2 Primary Sources
12.2 Disclaimer
12.3 Author Details
List of Tables
Table 1. Global Ex Vivo Organ Perfusion Market Size Growth Rate by Type (2026-2032) & (US$ Million)
Table 2. Key Players of Heart Perfusion
Table 3. Key Players of Liver Perfusion
Table 4. Key Players of Kidney Perfusion
Table 5. Key Players of Lung Perfusion
Table 6. Global Ex Vivo Organ Perfusion Market Size Growth by Application (2026-2032) & (US$ Million)
Table 7. Global Ex Vivo Organ Perfusion Market Size by Region (2026-2032) & (US$ Million)
Table 8. Global Ex Vivo Organ Perfusion Market Size by Region (2026-2032) & (US$ Million)
Table 9. Global Ex Vivo Organ Perfusion Market Share by Region (2026-2032)
Table 10. Market Top Trends
Table 11. Market Use Cases
Table 12. Global Ex Vivo Organ Perfusion Revenue by Players (2026 & 2032) & (US$ Million)
Table 13. Global Ex Vivo Organ Perfusion Market Share by Players (2026 & 2032)
Table 14. Key Players Headquarters and Area Served
Table 15. Key Players Ex Vivo Organ Perfusion Product/Solution/Service
Table 16. Date of Enter into Ex Vivo Organ Perfusion Market
Table 17. Mergers & Acquisitions, Expansion Plans
Table 18. Global Ex Vivo Organ Perfusion Market Size by Type (2026-2032) & (US$ Million)
Table 19. Global Ex Vivo Organ Perfusion Market Size Share by Type (2026-2032)
Table 20. Global Ex Vivo Organ Perfusion Market Size by Application (2026-2032) & (US$ Million)
Table 21. Global Ex Vivo Organ Perfusion Market Size Share by Application (2026-2032)
Table 22. North America Key Players Ex Vivo Organ Perfusion Revenue (2026 & 2032) & (US$ Million)
Table 23. North America Key Players Ex Vivo Organ Perfusion Market Share (2026 & 2032)
Table 24. North America Ex Vivo Organ Perfusion Market Size by Type (2026-2032) & (US$ Million)
Table 25. North America Ex Vivo Organ Perfusion Market Share by Type (2026-2032)
Table 26. North America Ex Vivo Organ Perfusion Market Size by Application (2026-2032) & (US$ Million)
Table 27. North America Ex Vivo Organ Perfusion Market Share by Application (2026-2032)
Table 28. Europe Key Players Ex Vivo Organ Perfusion Revenue (2026 & 2032) & (US$ Million)
Table 29. Europe Key Players Ex Vivo Organ Perfusion Market Share (2026 & 2032)
Table 30. Europe Ex Vivo Organ Perfusion Market Size by Type (2026-2032) & (US$ Million)
Table 31. Europe Ex Vivo Organ Perfusion Market Share by Type (2026-2032)
Table 32. Europe Ex Vivo Organ Perfusion Market Size by Application (2026-2032) & (US$ Million)
Table 33. Europe Ex Vivo Organ Perfusion Market Share by Application (2026-2032)
Table 34. Asia-Pacific Key Players Ex Vivo Organ Perfusion Revenue (2026 & 2032) & (US$ Million)
Table 35. Asia-Pacific Key Players Ex Vivo Organ Perfusion Market Share (2026 & 2032)
Table 36. Asia-Pacific Ex Vivo Organ Perfusion Market Size by Type (2026-2032) & (US$ Million)
Table 37. Asia-Pacific Ex Vivo Organ Perfusion Market Share by Type (2026-2032)
Table 38. Asia-Pacific Ex Vivo Organ Perfusion Market Size by Application (2026-2032) & (US$ Million)
Table 39. Asia-Pacific Ex Vivo Organ Perfusion Market Share by Application (2026-2032)
Table 40. Key Players in Latin America
Table 41. Key Players in Middle East & Africa
Table 42. TransMedics Company Details
Table 43. TransMedics Description and Business Overview
Table 44. TransMedics Ex Vivo Organ Perfusion Product
Table 45. TransMedics Revenue in Ex Vivo Organ Perfusion Business: 2026 & 2032
Table 46. TransMedics Recent Development
Table 47. Lung Bioengineering Company Details
Table 48. Lung Bioengineering Description and Business Overview
Table 49. Lung Bioengineering Ex Vivo Organ Perfusion Product
Table 50. Lung Bioengineering Revenue in Ex Vivo Organ Perfusion Business: 2026 & 2032
Table 51. Lung Bioengineering Recent Development
Table 52. OrganOx Company Details
Table 53. OrganOx Description and Business Overview
Table 54. OrganOx Ex Vivo Organ Perfusion Product
Table 55. OrganOx Revenue in Ex Vivo Organ Perfusion Business: 2026 & 2032
Table 56. OrganOx Recent Development
Table 57. XVIVO Company Details
Table 58. XVIVO Description and Business Overview
Table 59. XVIVO Ex Vivo Organ Perfusion Product
Table 60. XVIVO Revenue in Ex Vivo Organ Perfusion Business: 2026 & 2032
Table 61. XVIVO Recent Development
Table 62. TNO Company Details
Table 63. TNO Description and Business Overview
Table 64. TNO Ex Vivo Organ Perfusion Product
Table 65. TNO Revenue in Ex Vivo Organ Perfusion Business: 2026 & 2032
Table 66. TNO Recent Development
Table 67. UHN Company Details
Table 68. UHN Description and Business Overview
Table 69. UHN Ex Vivo Organ Perfusion Product
Table 70. UHN Revenue in Ex Vivo Organ Perfusion Business: 2026 & 2032
Table 71. UHN Recent Development
Table 72. SCREEN Company Details
Table 73. SCREEN Description and Business Overview
Table 74. SCREEN Ex Vivo Organ Perfusion Product
Table 75. SCREEN Revenue in Ex Vivo Organ Perfusion Business: 2026 & 2032
Table 76. SCREEN Recent Development
Table 77. Bridge to Life Company Details
Table 78. Bridge to Life Description and Business Overview
Table 79. Bridge to Life Ex Vivo Organ Perfusion Product
Table 80. Bridge to Life Revenue in Ex Vivo Organ Perfusion Business: 2026 & 2032
Table 81. Bridge to Life Recent Development
Table 82. Organ Recovery Systems Company Details
Table 83. Organ Recovery Systems Description and Business Overview
Table 84. Organ Recovery Systems Ex Vivo Organ Perfusion Product
Table 85. Organ Recovery Systems Revenue in Ex Vivo Organ Perfusion Business: 2026 & 2032
Table 86. Organ Recovery Systems Recent Development
Table 87. Institut Georges Lopez Company Details
Table 88. Institut Georges Lopez Description and Business Overview
Table 89. Institut Georges Lopez Ex Vivo Organ Perfusion Product
Table 90. Institut Georges Lopez Revenue in Ex Vivo Organ Perfusion Business: 2026 & 2032
Table 91. Institut Georges Lopez Recent Development
Table 92. Ebers Company Details
Table 93. Ebers Description and Business Overview
Table 94. Ebers Ex Vivo Organ Perfusion Product
Table 95. Ebers Revenue in Ex Vivo Organ Perfusion Business: 2026 & 2032
Table 96. Ebers Recent Development
Table 97. Penn Medicine Company Details
Table 98. Penn Medicine Description and Business Overview
Table 99. Penn Medicine Ex Vivo Organ Perfusion Product
Table 100. Penn Medicine Revenue in Ex Vivo Organ Perfusion Business: 2026 & 2032
Table 101. Penn Medicine Recent Development
Table 102. Johns Hopkins Medicine Company Details
Table 103. Johns Hopkins Medicine Description and Business Overview
Table 104. Johns Hopkins Medicine Ex Vivo Organ Perfusion Product
Table 105. Johns Hopkins Medicine Revenue in Ex Vivo Organ Perfusion Business: 2026 & 2032
Table 106. Johns Hopkins Medicine Recent Development
Table 107. Ex Vivo Organ Perfusion Market Trends
Table 108. Ex Vivo Organ Perfusion Market Drivers
Table 109. Ex Vivo Organ Perfusion Market Challenges
Table 110. Ex Vivo Organ Perfusion Market Restraints
Table 111. Research Programs/Design for This Report
Table 112. Key Data Information from Secondary Sources
Table 113. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Ex Vivo Organ Perfusion Market Share by Type in 2026 & 2032
Figure 2. Heart Perfusion Features
Figure 3. Liver Perfusion Features
Figure 4. Kidney Perfusion Features
Figure 5. Lung Perfusion Features
Figure 6. Global Ex Vivo Organ Perfusion Market Share by Application in 2026 & 2032
Figure 7. Organ Transplant Specialist Hospitals Case Studies
Figure 8. Organ Banks Case Studies
Figure 9. Pharmaceutical Research Organizations Case Studies
Figure 10. Ex Vivo Organ Perfusion Report Years Considered
Figure 11. Global Ex Vivo Organ Perfusion Market Size and Growth Rate 2026-2032 (US$ Million)
Figure 12. Global Ex Vivo Organ Perfusion Market Share by Region (2026-2032)
Figure 13. Global Ex Vivo Organ Perfusion Market Size Market Share by Type (2026-2032)
Figure 14. North America Ex Vivo Organ Perfusion Market Size 2026-2032 (US$ Million)
Figure 15. Europe Ex Vivo Organ Perfusion Market Size 2026-2032 (US$ Million)
Figure 16. Asia-Pacific Ex Vivo Organ Perfusion Market Size 2026-2032 (US$ Million)
Figure 17. Ex Vivo Organ Perfusion Market Size in Latin America (2026-2032) & (US$ Million)
Figure 18. Ex Vivo Organ Perfusion Market Size in Middle East & Africa (2026-2032) & (US$ Million)
Figure 19. Bottom-up and Top-down Approaches for This Report
Figure 20. Data Triangulation
Figure 21. Key Executives Interviewed
